Avian reovirus: a furious and fast evolving pathogen
J Med Microbiol. 2023 Oct;72(10). doi: 10.1099/jmm.0.001761.ABSTRACTAvian reoviruses (ARVs) have a significant economic impact on the poultry industry, affecting commercial and backyard flocks. Spread feco-orally, or vertically, many do not cause morbidity, but pathogenic strains can contribute to several diseases, including tenosynovitis/arthritis, which is clinically the most significant. The last decade has seen a surge in cases in the US, and due to ongoing evolution, seven genotypic clusters have now been identified. Control efforts include strict biosecurity and vaccination with commercial and autogenous vaccines. Re...
Source: Journal of Medical Microbiology - October 6, 2023 Category: Microbiology Authors: Sofia Egana-Labrin Andrew J Broadbent Source Type: research
Foodborne antimicrobial resistance (AMR) research and surveillance in the UK: priorities identified through the Food Standards Agency's AMR programme review (2023)
J Med Microbiol. 2023 Oct;72(10). doi: 10.1099/jmm.0.001753.NO ABSTRACTPMID:37801024 | DOI:10.1099/jmm.0.001753 (Source: Journal of Medical Microbiology)
Source: Journal of Medical Microbiology - October 6, 2023 Category: Microbiology Authors: Henry Nicholls Bobby Kainth Paul Cook Rick Mumford Charles Keevil Roberto La Ragione Eric Threlfall David McDowell Kathryn Callaghan Source Type: research
Efficacy of ceftobiprole in a murine model of bacteremia and disseminated infection
Conclusion. These results suggest that treatment with ceftobiprole using a 500 mg q8h dosing regimen studied in several successful phase three trials, has potential as an antibiotic therapy to treat bacteremia and associated disseminated infections caused by either methicillin-susceptible or methicillin-resistant strains of S. aureus.PMID:37791651 | DOI:10.1099/jmm.0.001755 (Source: Journal of Medical Microbiology)
Source: Journal of Medical Microbiology - October 4, 2023 Category: Microbiology Authors: Charlotte Cumper Claire Richards Jennifer Smart Karine Litherland Mark Jones Source Type: research
Efficacy of ceftobiprole in a murine model of bacteremia and disseminated infection
Conclusion. These results suggest that treatment with ceftobiprole using a 500 mg q8h dosing regimen studied in several successful phase three trials, has potential as an antibiotic therapy to treat bacteremia and associated disseminated infections caused by either methicillin-susceptible or methicillin-resistant strains of S. aureus.PMID:37791651 | DOI:10.1099/jmm.0.001755 (Source: Journal of Medical Microbiology)
Source: Journal of Medical Microbiology - October 4, 2023 Category: Microbiology Authors: Charlotte Cumper Claire Richards Jennifer Smart Karine Litherland Mark Jones Source Type: research
Efficacy of probiotics, prebiotics and synbiotics in irritable bowel syndrome: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials
Conclusions. Probiotics have a therapeutic role in IBS. However, the effect of different probiotics varies. The minimal effective dose of probiotics may be 109 c.f.u./day. With appropriate probiotic formula, the therapeutic effect can occur at 4 weeks. These data provide a basis for further research on the optimal probiotic therapy in IBS.PMID:37772692 | DOI:10.1099/jmm.0.001758 (Source: Journal of Medical Microbiology)
Source: Journal of Medical Microbiology - September 29, 2023 Category: Microbiology Authors: Wen Xue Zhang Lu Bo Shi Min Si Zhou Jing Wu Hai Yun Shi Source Type: research
Efficacy of probiotics, prebiotics and synbiotics in irritable bowel syndrome: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials
Conclusions. Probiotics have a therapeutic role in IBS. However, the effect of different probiotics varies. The minimal effective dose of probiotics may be 109 c.f.u./day. With appropriate probiotic formula, the therapeutic effect can occur at 4 weeks. These data provide a basis for further research on the optimal probiotic therapy in IBS.PMID:37772692 | DOI:10.1099/jmm.0.001758 (Source: Journal of Medical Microbiology)
Source: Journal of Medical Microbiology - September 29, 2023 Category: Microbiology Authors: Wen Xue Zhang Lu Bo Shi Min Si Zhou Jing Wu Hai Yun Shi Source Type: research
Efficacy of probiotics, prebiotics and synbiotics in irritable bowel syndrome: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials
Conclusions. Probiotics have a therapeutic role in IBS. However, the effect of different probiotics varies. The minimal effective dose of probiotics may be 109 c.f.u./day. With appropriate probiotic formula, the therapeutic effect can occur at 4 weeks. These data provide a basis for further research on the optimal probiotic therapy in IBS.PMID:37772692 | DOI:10.1099/jmm.0.001758 (Source: Journal of Medical Microbiology)
Source: Journal of Medical Microbiology - September 29, 2023 Category: Microbiology Authors: Wen Xue Zhang Lu Bo Shi Min Si Zhou Jing Wu Hai Yun Shi Source Type: research
Efficacy of probiotics, prebiotics and synbiotics in irritable bowel syndrome: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials
Conclusions. Probiotics have a therapeutic role in IBS. However, the effect of different probiotics varies. The minimal effective dose of probiotics may be 109 c.f.u./day. With appropriate probiotic formula, the therapeutic effect can occur at 4 weeks. These data provide a basis for further research on the optimal probiotic therapy in IBS.PMID:37772692 | DOI:10.1099/jmm.0.001758 (Source: Journal of Medical Microbiology)
Source: Journal of Medical Microbiology - September 29, 2023 Category: Microbiology Authors: Wen Xue Zhang Lu Bo Shi Min Si Zhou Jing Wu Hai Yun Shi Source Type: research
Efficacy of probiotics, prebiotics and synbiotics in irritable bowel syndrome: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials
Conclusions. Probiotics have a therapeutic role in IBS. However, the effect of different probiotics varies. The minimal effective dose of probiotics may be 109 c.f.u./day. With appropriate probiotic formula, the therapeutic effect can occur at 4 weeks. These data provide a basis for further research on the optimal probiotic therapy in IBS.PMID:37772692 | DOI:10.1099/jmm.0.001758 (Source: Journal of Medical Microbiology)
Source: Journal of Medical Microbiology - September 29, 2023 Category: Microbiology Authors: Wen Xue Zhang Lu Bo Shi Min Si Zhou Jing Wu Hai Yun Shi Source Type: research
PET-CT for characterising TB infection (TBI) in immunocompetent subjects: a systematic review
Conclusion. Our review provides some evidence, limited primarily to non-human primate models, of PET-CT utility as a highly sensitive imaging modality to reveal and characterise meaningful metabolic and structural change in early TBI. The few human studies identified exhibit considerable heterogeneity. Larger prospective studies are needed recruiting well characterised cohorts with TBI and adopting a standardized PET-CT protocol, to better understand utility of this imaging biomarker to support future research.PMID:37750439 | DOI:10.1099/jmm.0.001749 (Source: Journal of Medical Microbiology)
Source: Journal of Medical Microbiology - September 26, 2023 Category: Microbiology Authors: Jee Whang Kim Rayhan Munavvar Anver Kamil Pranabashis Haldar Source Type: research
PET-CT for characterising TB infection (TBI) in immunocompetent subjects: a systematic review
Conclusion. Our review provides some evidence, limited primarily to non-human primate models, of PET-CT utility as a highly sensitive imaging modality to reveal and characterise meaningful metabolic and structural change in early TBI. The few human studies identified exhibit considerable heterogeneity. Larger prospective studies are needed recruiting well characterised cohorts with TBI and adopting a standardized PET-CT protocol, to better understand utility of this imaging biomarker to support future research.PMID:37750439 | DOI:10.1099/jmm.0.001749 (Source: Journal of Medical Microbiology)
Source: Journal of Medical Microbiology - September 26, 2023 Category: Microbiology Authors: Jee Whang Kim Rayhan Munavvar Anver Kamil Pranabashis Haldar Source Type: research
PET-CT for characterising TB infection (TBI) in immunocompetent subjects: a systematic review
Conclusion. Our review provides some evidence, limited primarily to non-human primate models, of PET-CT utility as a highly sensitive imaging modality to reveal and characterise meaningful metabolic and structural change in early TBI. The few human studies identified exhibit considerable heterogeneity. Larger prospective studies are needed recruiting well characterised cohorts with TBI and adopting a standardized PET-CT protocol, to better understand utility of this imaging biomarker to support future research.PMID:37750439 | DOI:10.1099/jmm.0.001749 (Source: Journal of Medical Microbiology)
Source: Journal of Medical Microbiology - September 26, 2023 Category: Microbiology Authors: Jee Whang Kim Rayhan Munavvar Anver Kamil Pranabashis Haldar Source Type: research
Diagnostic efficiency of the FilmArray blood culture identification (BCID) panel: a systematic review and meta-analysis
Conclusions. The BCID panel has high rule-in value for the early detection of BSI patients. The BCID panel can still provide valuable information for ruling out bacteremia or fungemia in populations with low pretest probability.PMID:37712641 | DOI:10.1099/jmm.0.001608 (Source: Journal of Medical Microbiology)
Source: Journal of Medical Microbiology - September 15, 2023 Category: Microbiology Authors: Mei Yang Chuanmin Tao Source Type: research
Erratum: Utility of in-house and commercial PCR assay in diagnosis of Covid-19 associated mucormycosis in an emergency setting in a tertiary care center
J Med Microbiol. 2023 Sep;72(9). doi: 10.1099/jmm.0.001754.NO ABSTRACTPMID:37712654 | DOI:10.1099/jmm.0.001754 (Source: Journal of Medical Microbiology)
Source: Journal of Medical Microbiology - September 15, 2023 Category: Microbiology Authors: Mragnayani Pandey Janya Sachdev Renu Kumari Yadav Neha Sharad Anupam Kanodia Jaya Biswas R Sruti Janani Sonakshi Gupta Gagandeep Singh Meera Ekka Bhaskar Rana Sudesh Gourav Alok Thakar Ashutosh Biswas Kapil Sikka Purva Mathur Neelam Pushker Viveka P Jyots Source Type: research
Diagnostic efficiency of the FilmArray blood culture identification (BCID) panel: a systematic review and meta-analysis
Conclusions. The BCID panel has high rule-in value for the early detection of BSI patients. The BCID panel can still provide valuable information for ruling out bacteremia or fungemia in populations with low pretest probability.PMID:37712641 | DOI:10.1099/jmm.0.001608 (Source: Journal of Medical Microbiology)
Source: Journal of Medical Microbiology - September 15, 2023 Category: Microbiology Authors: Mei Yang Chuanmin Tao Source Type: research
